Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma.
Journal: Gynecologic oncology reports
Published: January 18, 2022
Probing Strong-Field QED with Doppler-Boosted Petawatt-Class Lasers.
Journal: Physical review letters
Published: December 15, 2020
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Journal: International journal of cancer
Published: January 29, 2019
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: September 21, 2015
β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers.
Journal: Gynecologic oncology
Published: April 16, 2014
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
Journal: Cancer research
Published: December 11, 2013
New strategies in endometrial cancer: targeting the PI3K/mTOR pathway--the devil is in the details.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 04, 2013
Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.
Journal: Expert opinion on pharmacotherapy
Published: August 14, 2013
Repurposing the Pap smear: one step closer to gynecologic cancer screening.
Journal: Science translational medicine
Published: January 11, 2013
Last Updated: 09/26/2026